Emily Boozalis is a Dermatology physician. OpenAlex indexes 31 publications with 521 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1618 S Millenium Way Ste 100
Meridian, ID 836426457
Telephone
208-884-3376Provider last certified this registry record 18 May 2026.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202516 payments
- Novartis Pharmaceuticals CorporationProgram year20254 payments
- Regeneron Healthcare Solutions, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
33.2%Azole Antifungal20.6%Ketoconazole100%Part D≥68 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.5%Valacyclovir100%Part D≥19 patients+ 2 more classes in this area
Sensory organs
18.8%Corticosteroid18.8%Clobetasol Propionate84%Hydrocortisone17%Part D≥66 patientsCancer & immunology
18%Nucleoside Metabolic Inhibitor12%Fluorouracil100%Part D≥55 patientsRetinoid4%Tretinoin100%Part D≥20 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 35303 Treatment practices and the use of web-based resources in prurigo nodularis
Journal of the American Academy of Dermatology
2022 - 35226 Characterization of pain in prurigo nodularis: An online survey-based study
Journal of the American Academy of Dermatology
2022 - Clinical characteristics and disease burden in prurigo nodularis
Clinical and Experimental Dermatology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Hywel C Williams
University of Nottingham
Mohsen Afarideh, MD, MPH
Mayo Clinic
Brigitte Dréno
Centre National de la Recherche Scientifique
Giovanni Damiani
University of Milan
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”